Interaction of Fat-stimulated Gastric Inhibitory Polypeptide on Pancreatic Alpha and Beta Cell Function
- 1 May 1980
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 65 (5) , 1119-1125
- https://doi.org/10.1172/jci109765
Abstract
Gastric inhibitory polypeptide (GIP) is considered to be the principal mediator of the enteroinsular axis. A glucose-insulin clamp technique was used to study the effects of differing blood glucose levels on the insulinotropic and glucagonotropic actions of fat-stimulated GIP in seven healthy subjects, as well as the effect of physiologic hyperinsulinemia on GIP secretion. Blood glucose levels were clamped for 4 h at 43±2 mg/dl (hypoglycemic clamp), 88±1 mg/dl (euglycemic clamp), and 141±2 mg/dl (hyperglycemic clamp) in the presence of a constant insulin infusion (100 m U/kg per h). Under hypoglycemic clamp conditions there was no increase in C-peptide nor glucagon after Lipomul ingestion, despite an increase of GIP of 51.7±8.7 ng/ml per 120 min. Under euglycemic clamp conditions, small and inconsistent increases in C-peptide and glucagon were observed after fat ingestion and a concomitant increase of GIP of 35.2±9.4 ng/ml per 120 min. Under hyperglycemic clamp conditions after fat ingestion and a GIP increase of 24.0±5.7 ng/ml per 120 min, C-peptide increased from 6.4±5 ng/ml to 11.0±1.1 ng/ml (P < 0.01) but glucagon did not change. These findings confirm that in healthy man GIP exerts its insulinotropic properties only under hyperglycemic conditions and indicate that GIP is not glucagonotropic. Under euglycemic clamp conditions (plasma glucose, 89±1 mg/dl) and physiologic hyperinsulinemia (serum immunoreactive insulin, 137±3 μU/ml) GIP responses to fat ingestion (39.7±9.8 ng/ml per 120 min) were not different from the GIP responses to fat ingestion in the absence of hyperinsulinemia (39.7±11.1 ng/ml per 120 min). Therefore, insulin under normoglycemic conditions does not exert an inhibitory effect on fat-stimulated GIP secretion. The higher GIP response to oral fat in the hypoglycemic clamp, and the lower GIP response in the hyperglycemic clamp compared to the response in the euglycemic clamp suggests an effect of glycemia itself on GIP secretion in the presence of hyperinsulinemia.This publication has 21 references indexed in Scilit:
- The Insulinotropic Action of Gastric Inhibitory Polypeptide in the Perfused Isolated Rat PancreasEndocrinology, 1976
- Gastric inhibitory polypeptide: Effect on glucose-induced insulin release from isolated rat pancreatic islets in vitroDiabetologia, 1975
- Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substancesThe American Journal of Surgery, 1975
- The Insulinotropic Action of Gastric Inhibitory PolypeptideCanadian Journal of Physiology and Pharmacology, 1975
- Identification and Actions of Gastric Inhibitory PolypeptidePublished by Elsevier ,1975
- Radioimmunoassay for Gastric Inhibitory PolypeptideGastroenterology, 1974
- STIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN.1Journal of Clinical Endocrinology & Metabolism, 1973
- The Effects of Triglyceride Absorption upon Glucagon, Insulin, and Gut Glucagon-Like ImmunoreactivityJournal of Clinical Investigation, 1973
- Abnormal Alpha-Cell Function in DiabetesNew England Journal of Medicine, 1970
- Coated Charcoal Immunoassay of InsulinJournal of Clinical Endocrinology & Metabolism, 1965